Cost-Effectiveness of Granulocyte Colony–Stimulating Factor Prophylaxis for Febrile Neutropenia in Breast Cancer in the United Kingdom

MLA

Whyte, Sophie, et al. “Cost-Effectiveness of Granulocyte Colony–Stimulating Factor Prophylaxis for Febrile Neutropenia in Breast Cancer in the United Kingdom.” Value in Health, vol. 14, no. 4, June 2011, pp. 465–74. EBSCOhost, https://doi.org/10.1016/j.jval.2010.10.037.

APA

Whyte, S., Cooper, K. L., Stevenson, M. D., Madan, J., & Akehurst, R. (2011). Cost-Effectiveness of Granulocyte Colony–Stimulating Factor Prophylaxis for Febrile Neutropenia in Breast Cancer in the United Kingdom. Value in Health, 14(4), 465–474. https://doi.org/10.1016/j.jval.2010.10.037

Chicago

Whyte, Sophie, Katy L. Cooper, Matt D. Stevenson, Jason Madan, and Ron Akehurst. 2011. “Cost-Effectiveness of Granulocyte Colony–Stimulating Factor Prophylaxis for Febrile Neutropenia in Breast Cancer in the United Kingdom.” Value in Health 14 (4): 465–74. doi:10.1016/j.jval.2010.10.037.